Rs 1,000 cr in 2 stocks: Ashish Kacholia’s big plays on weight loss and AI
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Ashish Kacholia holds Rs 1,000 crore in two stocks, betting on weight-loss drugs and AI.
- ✓He kept Shaily Engineering Plastics for eight years, which now makes injector pens for diabetes drugs.
- ✓A new Nashik cloud firm also joined his list after its 4th September 2026 listing.
Story at a Glance
- Category
- MARKET
- Reported By
- Financial Express
- Reading Speed
- 9 Minute(s)
- Market Focus
- India Economy
The first is a Vadodara plastics moulder he has held for over eight years. The second is a Nashik cloud and data centre firm that appears in his list for the first time this quarter. The latter only listed on 4th September 2026, and Kacholia’s 24.02 lakh shares were bought before the IPO, not on the market after it.
So, one position was built with patience. The other came through a private ticket that turned into a market frenzy. Both now trade at well over 65 times earnings, one riding the global weight-loss drug boom and the other India’s hunger for AI computing power. Let us dive in to see what sits beneath the price.
#1 Shaily Engineering Plastics: Kacholia’s 8-year bet now riding the semaglutide boom
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Financial Express
Read the full, original unfiltered story directly on the publisher's portal.